| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663293 ICAM-related protein |
| 09/02/1997 | US5663183 Cerebral disorders |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5663171 For use in humans or animals |
| 09/02/1997 | US5663157 For treating hyperproliferative diseases |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5662909 Potentiation of immunogenic response |
| 09/02/1997 | US5662900 Method of increasing interferon production in humans |
| 09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
| 08/28/1997 | WO1997031025A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 08/28/1997 | WO1997031024A1 Antibody variants |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/28/1997 | WO1997030999A1 Quinolones and their therapeutic use |
| 08/28/1997 | WO1997030990A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030989A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030726A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/28/1997 | CA2242598A1 Quinolones and their therapeutic use |
| 08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| 08/27/1997 | EP0791653A1 Human Fc-gamma receptor III |
| 08/27/1997 | EP0791594A2 2-Aryl-5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e 1,4 diazepines and their use for the preparation of pharmaceutical compositions for the treatment of HIV infection |
| 08/27/1997 | EP0791592A2 Azetidines |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | EP0594607B1 Enhancement of the down-regulation of autoimmune diseases by oral or enteral administration of autoantigens |
| 08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
| 08/27/1997 | EP0460116B1 9-substituted-8-unsubstituted-9-deazaguanines |
| 08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
| 08/27/1997 | CN1157852A Fermentation technology of Xylaria nigripes |
| 08/26/1997 | US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661159 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 08/26/1997 | US5661156 Administering to inhibit the growth of pathogenic fungi, to induce immunosuppression, and to treat carcinogenic tumors in humans and animals |
| 08/26/1997 | US5661015 Recombinant coccidiosis vaccines |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | US5660858 Cyclosporin emulsions |
| 08/26/1997 | CA2149245C Novel isoxazolines as antiinflammatory agents |
| 08/26/1997 | CA2140344C Antiinflammatory indolinyl n-hydroxyurea and n-hydroxamic acid derivatives |
| 08/26/1997 | CA1339389C Purified protein a compositions and methods for their preparation |
| 08/21/1997 | WO1997031000A1 Quinolones and their therapeutic use |
| 08/21/1997 | WO1997030171A1 Polysaccharide precipitation process |
| 08/21/1997 | WO1997030061A1 Methods of synthesizing gm2 |
| 08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
| 08/21/1997 | WO1997030029A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | WO1997029772A1 Recombinant canine herpesviruses |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997029743A1 Il-8 receptor antagonists |
| 08/21/1997 | WO1997029740A1 Multiple sclerosis treatment |
| 08/21/1997 | WO1997029645A1 Animal feed |
| 08/21/1997 | WO1997029635A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 08/21/1997 | WO1997029630A1 A method of preventing animals from diseases and improving immune function of animals |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | CA2245964A1 Animal feed |
| 08/21/1997 | CA2245927A1 Il-8 receptor antagonists |
| 08/21/1997 | CA2243662A1 Recombinant canine herpesviruses |
| 08/21/1997 | CA2241891A1 Quinolones and their therapeutic use |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | CA2217708A1 Methods of synthesizing gm2 |
| 08/21/1997 | CA2216465A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives |
| 08/20/1997 | EP0790309A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790308A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790255A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
| 08/20/1997 | EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790059A1 Means for treating auto-immune diseases and method of treatment |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789757A1 Transgenic organisms and their uses |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789710A1 Peptides for anti-allergy treatment |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789590A2 Chitosan induced immunopotentiation |
| 08/20/1997 | EP0789588A1 Method for making a medicament for treating secondary immunodeficiency |
| 08/20/1997 | EP0789580A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 08/20/1997 | EP0789576A1 Extract of crataegus, process for producing it and its use |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 08/20/1997 | EP0662954B1 Novel vitamin d analogues |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | CN1157619A Pyrimido £5-4-d| pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 08/20/1997 | CN1157618A Novel substituted purinyl derivatives with immunomodulating activity |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |